How to address the placebo response in the prescription SSRIs and SNRIs in children and adolescents

References

• Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European network for drug investigation in children. BMJ. 2000;320(7227):79–82.
   PubMed Web of Science ®Google Scholar
• Cramer K, Wiebe N, Moyer V, et al. Children in reviews: methodological issues in child-relevant evidence syntheses. BMC Pediatr. 2005;5:38.
   PubMedGoogle Scholar
• Martinez-Castaldi C, Silverstein M, Bauchner H. Child versus adult research: the gap in high-quality study design. Pediatrics. 2008;122(1):52–57.
   PubMed Web of Science ®Google Scholar
• Klassen TP, Hartling L, Craig JC, et al. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Medicine. 2008;5(8):1180–1182.
   Web of Science ®Google Scholar
• Janiaud P, Cornu C, Lajoinie A, et al. Is the perceived placebo effect comparable between adults and children? A meta-regression analysis. Pediatr Res. 2016;81(1–1):11–17.
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, Kakar R, McIntyre RS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol. 2015;19:2.
   Web of Science ®Google Scholar
• Fried EI, Nesse RM. Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential. BMC Med. 2015;13:72.
   PubMed Web of Science ®Google Scholar
• Locher C, Koechlin H, Zion SR, et al. Efficacy and safety of SSRIs, SNRIs, and placebo in common psychiatric disorders: a comprehensive meta-analysis in children and adolescents. JAMA Psychiatry. 2017;74(10):1011–1020.
   PubMed Web of Science ®Google Scholar
• Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683–1696.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Zhou XY, Del Giovane C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016;388(10047):881–890.
   PubMed Web of Science ®Google Scholar
• Zhou X, Cipriani A, Furukawa TA, et al. Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis. BMJ Open. 2018;8:1.
   Web of Science ®Google Scholar
• Stone MB. The FDA warning on antidepressants and suicidality–why the controversy? N Engl J Med. 2014;371(18):1668–1671.
   PubMed Web of Science ®Google Scholar
• Weimer K, Gulewitsch MD, Schlarb AA, et al. Placebo effects in children: a review. Pediatr Res. 2013;74(1):96–102.
   PubMed Web of Science ®Google Scholar
• Wampold BE, Minami T, Tierney SC, et al. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol. 2005;61(7):835–854.
   PubMed Web of Science ®Google Scholar
• Krummenacher P, Kossowsky J, Schwarz C, et al. Expectancy-induced placebo analgesia in children and the role of magical thinking. J Pain. 2014;15(12):1282–1293.
   PubMed Web of Science ®Google Scholar
• Strawn JR, Mills JA, Sauley B, et al. The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: a meta-analysis. J Am Acad Child Adolesc Psychiatry. 2018;57(4):235–244.
   PubMed Web of Science ®Google Scholar
• Rutherford BR, Sneed JR, Tandler JM, et al. Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact. J Am Acad Child Adolesc Psychiatry. 2011;50(8):782–795.
   PubMed Web of Science ®Google Scholar
• Bridge JA, Birmaher B, Iyengar S, et al. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry. 2009;166(1):42–49.
   PubMed Web of Science ®Google Scholar
• Trachsel M, Gaab J. Disclosure of incidental constituents of psychotherapy as a moral obligation for psychiatrists and psychotherapists. J Med Ethics. 2016;42(8):493–495.
   PubMed Web of Science ®Google Scholar
• McKay KM, Imel ZE, Wampold BE. Psychiatrist effects in the psychopharmacological treatment of depression. J Affect Disord. 2006;92(2–3):287–290.
   PubMed Web of Science ®Google Scholar
• Bystad MK, Bystad C, Wynn R. How can placebo effects best be applied in clinical practice? A narrative review. Psychology Res Behav Manag. 2015;8:41-45.
   Web of Science ®Google Scholar
• Sandler AD, Glesne CE, Bodfish JW. Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 2010;31(5):369–375.
   PubMed Web of Science ®Google Scholar
• Charlesworth JEG, Petkovic G, Kelley JM, et al. Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis. J Evid Based Med. 2017;10(2):97–107.
   PubMedGoogle Scholar
• Locher C, Frey Nascimento A, Kossowsky J, et al. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. Pain. 2017;158(12):2320–2328.
   PubMed Web of Science ®Google Scholar
• Kelley JM, Kaptchuk TJ, Cusin C, et al. Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychother and Psychosom. 2012;81(5):312–314.
   PubMed Web of Science ®Google Scholar
• Kaptchuk TJ, Friedlander E, Kelley JM, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010;5:12.
   Web of Science ®Google Scholar
• Sandler AD, Bodfish JW. Open-label use of placebos in the treatment of ADHD: a pilot study. Child Care Health Dev. 2008;34(1):104–110.
   PubMed Web of Science ®Google Scholar